United Kingdom · Venture startup

Who invested in Scancell

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$4.6Mraised across 2 rounds since 2004, from 2 sources

$2.3MVenture$2.3MVenture
Latest round
Venture, $2.3MMay 2005
Biggest round
$2.3MVenture · Apr 2004
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2005
$2.3MVenture$2.3MVenture
First round
Venture, $2.3M
Apr 2004
Biggest round
$2.3M
Venture · Apr 2004
Between rounds
13 months
from the last two

The rounds

  1. May 2005
    Venture$2.3M3 returning

    From a historical funding record

  2. Apr 2004

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Bioscience VCTInvestment firm2rounds
Cherwell Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Scancell

Who invested in Scancell?

Scancell's investors include Oxford Capital Partners, Oxford Technology Management, Bioscience VCT and Cherwell Capital.

How much has Scancell raised?

Scancell has raised $4.6M across 2 rounds since 2004.

When did Scancell last raise?

Scancell's most recent round was a Venture of $2.3M in May 2005.

What was Scancell's biggest round?

Scancell's largest round on record is $2.3M (Venture), in Apr 2004.

Who backed Scancell first?

Scancell's first round on record, in Apr 2004, was backed by Oxford Capital Partners, Oxford Technology Management and Bioscience VCT and 1 others.

What stage is Scancell at?

Scancell's latest named round is a Venture, in May 2005.

Where is Scancell based?

Scancell is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.